Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. GELS
GELS logo

GELS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GELS News

Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%

Jan 14 2026Benzinga

U.S. Stock Futures Decline as CPI Rises 2.7% Year Over Year

Jan 14 2026Benzinga

Bank of America Expected to Report $0.96 EPS on $27.87 Billion Revenue

Jan 14 2026Benzinga

Gelteq Ltd. (NASDAQ:GELS) Shares Surge 69.25% on Positive Preclinical Results

Jan 14 2026Benzinga

Gelteq Partners with Hong Kong Flag Football Program, Secures $1.3M Annual Revenue Commitment

Dec 16 2025Globenewswire

Gelteq Partners with Hong Kong Flag Football Program, Securing $1.3M Annual Revenue

Dec 16 2025Newsfilter

Gelteq Enters 3-Year Sales Agreement with Mana, Projecting $1.3M Revenue

Dec 09 2025Globenewswire

Gelteq's Novel Oral Delivery System Significantly Enhances Bioavailability

Dec 05 2025Globenewswire

Gelteq Reports 38-45% Bioavailability Increase in New Antihistamine Gel Formulation

Nov 24 2025Newsfilter

Gelteq Partners with Melbourne Health to Develop Innovative Compound for Reducing Bowel Polyp Growth

Oct 09 2025Newsfilter

Gelteq Technology Supports U.S. Launch of Nutraceutical Products for Partner

Sep 12 2025Newsfilter

3 Penny Stocks to Keep an Eye on as of September 8, 2025

Sep 08 2025TipRanks

Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities

Jul 17 2025Newsfilter

Why Stitch Fix Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Jun 11 2025Benzinga

Gelteq Expands US Footprint With Healthy Extracts Logistics Deal, Stock Surges

Jun 10 2025Benzinga

Gelteq Signs U.S. Fulfillment Deal With Healthy Extracts To Boost North American Reach

Jun 10 2025NASDAQ.COM